Specialist evaluation and surgical management of parathyroid disorders, including parathyroid adenomas, hyperparathyroidism and selected parathyroid tumours.
The parathyroid glands are four small glands located near the thyroid gland in the neck. They produce parathyroid hormone, also known as PTH, which plays an important role in regulating calcium levels in the body.
When one or more parathyroid glands become overactive, they may produce excessive amounts of PTH. This can affect calcium levels and may have consequences for the bones, kidneys and other systems of the body.
A parathyroid adenoma is a common cause of primary hyperparathyroidism. Treatment depends on the underlying condition, laboratory findings, imaging results, symptoms and the patient's overall health.
Abnormal parathyroid hormone production can disturb calcium balance throughout the body. Appropriate evaluation helps determine whether observation, medical management or surgery should be considered.
Parathyroid disorders can have different causes and may affect calcium and PTH levels in different ways. A detailed evaluation helps determine the appropriate treatment approach.
A usually benign growth of a parathyroid gland that can result in excessive production of parathyroid hormone.
A condition in which one or more parathyroid glands produce excessive PTH, often associated with elevated calcium levels.
Enlargement or overactivity involving multiple parathyroid glands may require a different treatment and surgical plan.
Persistent or recurrent abnormal PTH levels after previous treatment may require detailed reassessment and localisation.
A rare malignant tumour of the parathyroid gland requiring specialist assessment and appropriate oncological planning.
Increased parathyroid activity may occur as a response to other medical conditions and requires evaluation of the underlying cause.
Some people with parathyroid disorders may have few or no noticeable symptoms. Others may develop symptoms related to abnormal calcium levels.
Bone pain, weakness or reduced bone density may occur in some patients.
Persistently elevated calcium levels can contribute to kidney stone formation.
Some patients may experience persistent tiredness or reduced energy.
Changes in calcium balance may be associated with increased thirst and urination.
High calcium levels can affect kidney function and urinary patterns.
Nausea, constipation or abdominal discomfort may occur in some patients.
Some patients may report difficulty concentrating, irritability or changes in mood.
Abnormal calcium and PTH levels can sometimes contribute to muscle weakness.
Diagnosis usually begins with blood tests that assess calcium, parathyroid hormone and other relevant parameters. Additional testing may be recommended based on the clinical situation.
Helps determine whether calcium levels are elevated.
Measures PTH levels and helps establish the biochemical diagnosis.
Additional laboratory tests can help identify contributing factors.
May help identify an enlarged or abnormal parathyroid gland.
A nuclear medicine scan may help localise abnormal parathyroid tissue.
Advanced imaging may be considered when localisation is difficult.
When surgery is recommended, the procedure is planned according to the suspected gland involved, imaging findings and the underlying cause of hyperparathyroidism.
When preoperative imaging localises an abnormal gland, a focused surgical approach may be considered in appropriate patients.
Selected patients may be candidates for a smaller targeted operation depending on the clinical and imaging assessment.
When multiple-gland disease is suspected or localisation is uncertain, exploration of the relevant glands may be required.
Persistent or recurrent disease after previous surgery may require detailed review and advanced localisation.
Parathyroid surgery requires careful assessment of the biochemical diagnosis and available imaging before an appropriate surgical approach is selected.
Calcium, PTH and other relevant laboratory values are reviewed to confirm the underlying biochemical abnormality.
Imaging such as ultrasound, sestamibi scanning or advanced cross-sectional imaging may be used when appropriate.
The operative plan is selected according to the suspected disease pattern, previous treatment and available findings.
Appropriate follow-up helps assess calcium and PTH levels after treatment.
Follow-up helps assess calcium and PTH levels and identify postoperative changes that may require attention.
Calcium levels may be monitored after surgery according to the clinical situation.
Symptoms such as tingling, muscle cramps or weakness may be assessed if calcium levels change.
Follow-up calcium and PTH testing can help evaluate the biochemical response to treatment.
Further follow-up depends on the original diagnosis, postoperative findings and individual clinical needs.
Complex parathyroid cases may require coordinated assessment involving endocrine, radiology, pathology, anaesthesia and surgical teams depending on the diagnosis.
Not every patient with an abnormal calcium or PTH level requires surgery. The decision depends on the diagnosis, biochemical findings, symptoms, imaging and other relevant health factors.
For patients who require an operation, the surgical approach is planned after reviewing the available laboratory and imaging information.
The objective is to address the underlying parathyroid condition while taking appropriate care around nearby thyroid, nerve and other neck structures.
A structured evaluation can help patients understand their diagnosis and the available treatment options.
Review symptoms, medical history, previous reports and laboratory results.
Confirm the biochemical diagnosis and perform localisation studies when required.
Discuss observation, medical management or surgery according to the individual clinical situation.
Monitor recovery and relevant calcium and PTH levels after treatment.
Dr. Nitin Singhal is a surgical oncologist in Ahmedabad with experience in the evaluation and surgical management of different cancer and complex surgical conditions.
His surgical practice includes gastrointestinal, colorectal, gynecological, urological, thoracic, head and neck and other oncological procedures, including selected robotic cancer surgeries.
Parathyroid disorders can cause changes in calcium and parathyroid hormone levels and may affect the bones, kidneys and other parts of the body. Parathyroid adenoma is one of the conditions that may lead to primary hyperparathyroidism.
Evaluation generally involves blood tests for calcium and parathyroid hormone, along with additional investigations when appropriate. Imaging can help identify the location of an abnormal gland and may assist in surgical planning.
Parathyroidectomy may be recommended for selected patients after assessment of their symptoms, biochemical results, imaging findings and overall clinical situation. The type of surgery depends on whether one or multiple glands are suspected to be involved and whether the patient has undergone previous surgery.
If you have been diagnosed with hyperparathyroidism, an abnormal calcium level or a suspected parathyroid tumour, a specialist consultation can help determine the appropriate next step.
Every patient's diagnosis and treatment plan is individual. Understanding the condition and available options is an important part of the consultation process.
Understanding the diagnosis, investigations and treatment options can help patients make informed decisions about their care.
Clear communication about investigations and treatment planning is an important part of specialist surgical care.
A structured consultation can help patients understand their diagnosis, treatment options and follow-up plan.
Answers to common questions about parathyroid conditions, diagnosis and surgery.
The parathyroid glands are small glands in the neck that regulate calcium levels by producing parathyroid hormone, or PTH.
A parathyroid adenoma is a usually benign growth of a parathyroid gland that can produce excessive parathyroid hormone.
No. Treatment depends on the underlying cause, calcium and PTH levels, symptoms, imaging findings and the patient's overall clinical situation.
Evaluation may include calcium and PTH blood tests along with other laboratory investigations and imaging such as ultrasound or sestamibi scanning when appropriate.
Parathyroidectomy is surgery to remove an abnormal or overactive parathyroid gland or glands.
Selected patients may be suitable for a focused or minimally invasive approach when the abnormal gland has been appropriately localised.
Calcium levels may be monitored after surgery, with further follow-up based on the patient's diagnosis, symptoms and postoperative laboratory results.
Parathyroid carcinoma is rare. Suspected malignant disease requires specialist evaluation and an appropriate surgical and oncological treatment plan.
If you have abnormal calcium or PTH levels, a suspected parathyroid adenoma or have been advised to consider surgery, schedule a consultation to discuss your reports and treatment options.
Dr. Nitin Singhal has been recognised for his contribution to cancer care and surgical oncology, reflecting his commitment to advanced surgical techniques, clinical excellence and patient-centred care.
Surgical oncology training from Tata Memorial Hospital, Mumbai.
Expertise across complex and multidisciplinary cancer surgery.
Honoured for excellence in healthcare and surgical oncology.
Focus on evidence-based and personalised cancer treatment.
Recognition that reflects a continued commitment to excellence in cancer care.
